These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
232 related articles for article (PubMed ID: 17546112)
1. Rapid determination of fluconazole susceptibilities for clinical specimens with possible polymicrobial Candida spp. Chiew YF; Inwood H N Z Med J; 2007 Jun; 120(1255):U2567. PubMed ID: 17546112 [No Abstract] [Full Text] [Related]
2. Rapid identification of fluconazole resistance using Chrom agar Candida. Verghese SL; Padmaja P; Sutha P; Mathew T; Johni ES Indian J Pathol Microbiol; 2001 Jul; 44(3):305-7. PubMed ID: 12024918 [TBL] [Abstract][Full Text] [Related]
3. Rapid identification of fluconazole resistance using Chromagar Candida. Verghese SL; Padmaja P; Sutha P; Mathew T; John ES Indian J Pathol Microbiol; 2000 Jul; 43(3):343-6. PubMed ID: 11218683 [TBL] [Abstract][Full Text] [Related]
4. Rationale for reading fluconazole MICs at 24 hours rather than 48 hours when testing Candida spp. by the CLSI M27-A2 standard method. Ostrosky-Zeichner L; Rex JH; Pfaller MA; Diekema DJ; Alexander BD; Andes D; Brown SD; Chaturvedi V; Ghannoum MA; Knapp CC; Sheehan DJ; Walsh TJ Antimicrob Agents Chemother; 2008 Nov; 52(11):4175-7. PubMed ID: 18809944 [TBL] [Abstract][Full Text] [Related]
5. In vitro interaction of micafungin and fluconazole against Candida. Rodríguez MM; Ruiz M; Pastor FJ; Quindós G; Carrillo A; Guarro J J Antimicrob Chemother; 2007 Jul; 60(1):188-90. PubMed ID: 17525050 [No Abstract] [Full Text] [Related]
6. In vitro susceptibility of breakthrough Candida bloodstream isolates correlates with daily and cumulative doses of fluconazole. Clancy CJ; Staley B; Nguyen MH Antimicrob Agents Chemother; 2006 Oct; 50(10):3496-8. PubMed ID: 17005842 [TBL] [Abstract][Full Text] [Related]
7. Community-acquired fungemia due to a multiple-azole-resistant strain of Candida tropicalis. Jandourek A; Brown P; Vazquez JA Clin Infect Dis; 1999 Dec; 29(6):1583-4. PubMed ID: 10585825 [No Abstract] [Full Text] [Related]
8. Susceptibilities to amphotericin B and fluconazole of Candida species in Taiwan Surveillance of Antimicrobial Resistance of Yeasts 2006. Yang YL; Wang AH; Wang CW; Cheng WT; Li SY; Lo HJ; Diagn Microbiol Infect Dis; 2008 Jun; 61(2):175-80. PubMed ID: 18304773 [TBL] [Abstract][Full Text] [Related]
9. Comparison of the Vitek 2 system with the CLSI broth microdilution, disk diffusion, and sterol quantitation methods for determining fluconazole susceptibility against Candida spp. Kim TH; Lee MK Clin Chem Lab Med; 2010 Feb; 48(2):297-8. PubMed ID: 20131969 [No Abstract] [Full Text] [Related]
10. [Changes in epidemiology of opportunistic infections due to Candida]. Odds FC Rev Clin Esp; 1995 Oct; 195 Suppl 3():1-3. PubMed ID: 9441300 [No Abstract] [Full Text] [Related]
11. Fluconazole and itraconazole susceptibilities of Candida spp. isolated from oropharyngeal specimens and blood cultures of paediatric haematology/oncology patients. Kennedy HF; Shankland GS; Bagg J; Chalmers EA; Gibson BE; Williams CL Mycoses; 2006 Nov; 49(6):457-62. PubMed ID: 17022761 [TBL] [Abstract][Full Text] [Related]
12. Disk diffusion test and E-test with enriched Mueller-Hinton agar for determining susceptibility of Candida species to voriconazole and fluconazole. Lee SC; Lo HJ; Fung CP; Lee N; See LC J Microbiol Immunol Infect; 2009 Apr; 42(2):148-53. PubMed ID: 19597647 [TBL] [Abstract][Full Text] [Related]
13. Species distribution and antifungal susceptibility patterns of clinical Candida isolates in North Lebanon: A pilot cross-sectional multicentric study. Osman M; Al Bikai A; Rafei R; Mallat H; Dabboussi F; Hamze M J Mycol Med; 2020 Sep; 30(3):100986. PubMed ID: 32417178 [No Abstract] [Full Text] [Related]
14. Direct fluconazole susceptibility testing of positive Candida blood cultures by flow cytometry. Rudensky B; Broide E; Berko N; Wiener-Well Y; Yinnon AM; Raveh D Mycoses; 2008 May; 51(3):200-4. PubMed ID: 18399900 [TBL] [Abstract][Full Text] [Related]
15. Correlation between CLSI, EUCAST and Etest methodologies for amphotericin B and fluconazole antifungal susceptibility testing of Candida spp. clinical isolates. Claudino AL; Peixoto RF; Melhem MS; Szeszs MW; Lyon JP; Chavasco JK; Franco MC Pharmazie; 2008 Apr; 63(4):286-9. PubMed ID: 18468388 [TBL] [Abstract][Full Text] [Related]
16. In vitro activity of essential oils extracted from plants used as spices against fluconazole-resistant and fluconazole-susceptible Candida spp. Pozzatti P; Scheid LA; Spader TB; Atayde ML; Santurio JM; Alves SH Can J Microbiol; 2008 Nov; 54(11):950-6. PubMed ID: 18997851 [TBL] [Abstract][Full Text] [Related]
17. Persistent Candida parapsilosis funguria associated with an indwelling urinary tract stent for more than 7 years. Ruan SY; Chien JY; Hsueh PR J Med Microbiol; 2008 Dec; 57(Pt 12):1585-1587. PubMed ID: 19018034 [TBL] [Abstract][Full Text] [Related]
18. Candida rugosa: a distinctive emerging cause of candidaemia. A case report and review of the literature. Minces LR; Ho KS; Veldkamp PJ; Clancy CJ Scand J Infect Dis; 2009; 41(11-12):892-7. PubMed ID: 19922077 [TBL] [Abstract][Full Text] [Related]
19. Activities of fluconazole and voriconazole against bloodstream isolates of Candida glabrata and Candida krusei: a 14-year study in a Spanish tertiary medical centre. Quindós G; Sánchez-Vargas LO; Villar-Vidal M; Eraso E; Alkorta M; Hernández-Almaraz JL Int J Antimicrob Agents; 2008 Mar; 31(3):266-71. PubMed ID: 18054468 [TBL] [Abstract][Full Text] [Related]
20. A global evaluation of voriconazole activity tested against recent clinical isolates of Candida spp. Diekema DJ; Messer SA; Hollis RJ; Boyken L; Tendolkar S; Kroeger J; Jones RN; Pfaller MA Diagn Microbiol Infect Dis; 2009 Feb; 63(2):233-6. PubMed ID: 19070452 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]